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Abstract
Pancreatic b-cells play central roles in blood glucose homeostasis. Beside insulin, these cells release neurotransmitters and
other signaling molecules stored in synaptic-like microvesicles (SLMVs). We monitored SLMV exocytosis by transfecting a
synaptophysin-pHluorin construct and by visualizing the cells by Total Internal Reflection Fluorescence (TIRF) microscopy.
SLMV fusion was elicited by 20 mM glucose and by depolarizing K+ concentrations with kinetics comparable to insulin
secretion. SLMV exocytosis was prevented by Tetanus and Botulinum-C neurotoxins indicating that the fusion machinery of
these organelles includes VAMP-2/-3 and Syntaxin-1, respectively. Sequential visualization of SLMVs by TIRF and
epifluorescence microscopy showed that after fusion the vesicle components are rapidly internalized and the organelles re-
acidified. Analysis of single fusion episodes revealed the existence of two categories of events. While under basal conditions
transient fusion events prevailed, long-lasting episodes were more frequent upon secretagogue exposure. Our observations
unveiled similarities between the mechanism of exocytosis of insulin granules and SLMVs. Thus, diabetic conditions
characterized by defective insulin secretion are most probably associated also with inappropriate release of molecules
stored in SLMVs. The assessment of the contribution of SLMV exocytosis to the manifestation of the disease will be
facilitated by the use of the imaging approach described in this study.
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Introduction
Tight control of insulin release from pancreatic ß-cells plays an
essential role in the achievement of blood glucose homeostasis.
Insufficient insulin supply, resulting from b-cell dysfunction and/
or from reduction of the b-cell mass, leads to chronic hypergly-
cemia and favors the development of different forms of diabetes
mellitus, the most common metabolic disorder worldwide [1,2].
Pancreatic b-cells are located in aggregates of endocrine cells, the
islets of Langerhans, which include also a-, c-, PP- and e-cells
secreting glucagon, somatostatin, pancreatic polypeptide and
ghrelin, respectively [3]. Islet cells are all involved in the control
of metabolic functions and some of the hormones they release have
opposite effects. Consequently, the secretory activity of islet cells
has to be highly coordinated. To achieve this goal, islet cells
release a wide array of molecules displaying autocrine and
paracrine functions. Indeed, besides insulin, pancreatic b-cells
secrete Islet Amyloid Polypeptide, Zn2+, ATP as well as several
neurotransmitters [4,5] that have putative local signaling func-
tions. Some of these molecules are stored in insulin-containing
large dense-core vesicles (LDCVs) and are co-released with insulin
[6]. However, others are located in distinct organelles with a
diameter of 50–90 nm that closely resemble neuronal secretory
vesicles called synaptic-like microvesicles (SLMVs). These secre-
tory organelles contain synaptic vesicle proteins such as synapto-
physin and are likely to function as vehicles for storage and release
of signaling molecules. [7,8,9]. The precise content of b-cell
SLMVs is still unclear but they store at least two major inhibitory
neurotransmitters, glycine and c-Aminobutyric acid (GABA) [9].
The physiological role of these neurotransmitters in the islets of
Langerhans is only beginning to unfold but GABA has already
been shown to inhibit glucagon secretion from pancreatic b-cells
and to display autocrine effects on the secretory properties and
proliferation of b-cells, suggesting an important contribution in the
control of pancreatic endocrine functions [4,10,11].
Insulin release can be triggered by different nutrients, hormones
and neurotransmitters. Glucose, the main physiological stimulus,
enters the cells and its metabolic transformation leads to an
increase in the ATP/ADP ratio with the consequent closure of
ATP-sensitive K+ channels and the depolarization of the plasma
membrane. These events cause the opening of voltage-gated Ca2+
channels and a rise in the intracellular free Ca2+ concentration.
The increase of Ca2+ combined with the production of other
metabolic factors triggers the fusion of LDCVs with the plasma
membrane. During the last twenty years, the molecular mecha-
nisms regulating insulin exocytosis have been intensively investi-
gated and many of the components of the machinery governing
the secretory process of LDCVs have been identified (for review
see [12]). In contrast, the mechanisms and the signaling pathways
controlling SLMV exocytosis have been poorly explored because
of the characteristics of these organelles. In fact, SLMVs are much
smaller than LDCVs rendering more challenging their study by
capacitance measurements. Moreover, their content is still poorly
defined and several molecules filling SLMVs are also stored in
LDCVs. Therefore, it is difficult to follow specifically SLMV
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exocytosis using standard biochemical techniques or conventional
electrophysiological approaches such as amperometry.
In this study, we used a live imaging approach to specifically
investigate SLMV exocytosis from pancreatic b-cells. This
methodology was used to define the signaling cascades that trigger
SLMV release, to identify some of the key components that govern
SLMV exocytosis and to determine the kinetics of fusion and
recycling of SLMVs.
Materials and Methods
Chemicals
Bafilomycin A1, epinephrine, nifedipine and somatostatin were
purchased from Sigma (Buchs, Switzerland). Calibration beads
were from Molecular Probes (Zug, Switzerland). The antibodies
against GFP, Insulin and Synaptophysin were from Chemicon
(Zug, Switzerland), Abcam (Cambridge, UK) and Sigma (Buchs,
Switzerland), respectively. All other chemicals (unless indicated)
were obtained from Invitrogen (Basel, Switzerland).
Plasmids
The synaptophysin-pHluorin plasmid used for TIRF imaging
was generously provided by Dr L. Lagnado (MRC Laboratory of
Molecular Biology, Cambridge, U.K.) [13]. The pmCherry-N1
and pEGFP-C2 vector were purchases from Clontech Laborato-
ries (Allschwil, Switzerland). The Tetanus neurotoxin-Tomato
construct [14] was kindly provided by Dr. N. Ben Fredj (MRC
Centre for Developmental Neurobiology, King’s College London,
U.K.). The enhanced GFP-Botulinum neurotoxin C1 construct
was obtained from Dr. J. Lang (University of Bordeaux, CBMN,
UMR 5248, France). The synaptophysin-mCherry plasmid was
produced in our laboratory by subcloning. For this purpose, a
plasmid encoding rat synaptophysin 1-EGFP obtained from Dr. Y.
Goda (MRC Laboratory of Molecular Cell Biology, Cell Biology
Unit, University College London, U.K.) was cleaved between the
XhoI and AgeI sites to isolate the coding sequence of rat
synaptophysin 1. The DNA fragment was then inserted between
the XhoI and AgeI cloning sites of pmCherry-N1.
Cell Culture and Transient Transfections
The insulin-secreting cell line MIN6 clone B1 [15] was cultured
in DMEM-Glutamax medium supplemented with 15% fetal calf
serum, 70 mM b-Mercaptoethanol, 50 units/ml penicillin and
50 mg/ml streptomycin. Transient transfection experiments were
performed as described [16] using Lipofectamine 2000. Co-
transfection experiments were performed using a plasmid DNA
ratio of 1:1.
Immunocytochemistry
MIN6 cells were plated on glass coverslips coated with 2 mg/
ml poly-L-lysine and 33 mg/ml laminin and cultured for 2 days.
The cells were rinsed with phosphate-buffered saline (PBS) and
fixed in ice-cold methanol for 15 min at room temperature.
After two washes in ice-cold PBS, the coverslips were incubated
for 10 min with PBS containing 0.5% saponin (PBS-S) and
rinsed three times 5 min with PBS. They were then incubated
for 30 min in PBS-S containing 1% Bovine Serum Albumin
(BSA) and for 1 hour at room temperature in the presence of
the primary antibodies diluted in PBS-S plus 1% BSA. The cells
were rinsed with PBS, incubated 1 hour with the secondary
antibody and mounted for confocal microscopy (Leica SP5
AOBS Confocal Microscope).
Cell Cultures for Imaging Experiments
MIN6 cells (3.56105) were plated on glass coverslips coated
with 2 mg/ml poly-L-lysine and 33 mg/ml laminin. The cells
were transfected with synaptophysin-pHluorin [13], synaptophy-
sin-mCherry or phogrin-mCherry constructs. MIN6 cells were
transiently cotransfected with syp-pHluorin and empty pmCherry-
N1 or empty eGFP-C2 for controls or cotransfected with syp-
pHluorin and plasmids encoding either Tetanus neurotoxin-
tomato (TeTx) or enhanced GFP-Botulinum neurotoxin C1
(BoNT/C). Two to four days after transfection, the coverslips
were mounted in an experimental chamber at 37uC (Harvard
Apparatus) on the stage of a Zeiss Axiovert 200 fluorescence
inverted microscope modified to allow epifluorescence (EPI) and
evanescence field (TIRF) illumination (Visitron System)
[17,18,19]. Cells were perfused at 37uC in Krebs-Ringer
bicarbonate-HEPES buffer (KRBH: 127 mM NaCl, 4.7 mM
KCl, 1.2 mM KH2PO4,1.2 mM MgSO4, 1 mM CaCl2, 5 mM
NaHCO3, 25 mM HEPES, pH 7.4) containing 2 mM glucose
(basal solution). They were stimulated with a combination of
secretagogues including: KRBH containing 20 mM glucose,
30 mM KCl, 10 mM Forskolin and 100 mM IBMX, KRBH
containing 20 mM glucose or 30 mM KCl. Bafilomycin A1 was
used at a final concentration of 2.5 mM (diluted with KRBH
containing 2 mM glucose) and incubated for 5 min before the
stimulus. Nifedipine was used at a final concentration of 10 mM
diluted with basal solution, incubated for 15 min before and
during all the experiment. In experiments with somatostatin
(500 nM) or epinephrine (1 mM), the drugs were diluted in the
stimulatory solution and were present throughout the stimulation
period.
Optical Imaging and Data Acquisition
EPI or TIRF illuminations were used for our experiments. In
Bafilomycin A1 experiments, EPI and TIRF illuminations were
alternated in real time for whole-cell pHluorin fluorescence (pHF)
signal measurements in individual cells, in basal condition and
upon stimulation. By imaging with excitation light at 488 nm
generated by a 488 nm laser (20 mW; Laserphysics) and by a
polychromator illumination system (Visichrome), the pHF signal
was recorded at 10 Hz through a 100X objective lens (a-plan
FLUAR 100X, 1.45 NA, Zeiss, Germany) and filtered with Zeiss
filter set 10 (Zeiss) [19]. For TIRF illumination, the expanded
beam (488/568 nm argon/krypton multilinelaser, 20 mW) (La-
serphysics, USA) was passed through an AOTF laser wavelength
selector (VisiTech International) synchronized with a SNAP-HQ
CCD camera (Roper Scientific, Germany) under Metafluor
software (Universal Imaging, USA) control and was introduced
from the high numerical aperture objective lens (a-plan FLUAR
100X, 1.45 NA, Zeiss, Germany). Light entered the coverslips and
underwent total internal reflection at the glass-cell interface. In our
experimental conditions, penetration depth of TIRF illumination
was calculated to be about 90 nm [20]. Light was filtered with a
beam splitter (Zeiss filter set 10). Images were acquired at 20–
40 Hz. Pixel size 126 nm at binning 2.
Image Analysis
Video images were digitized with Metafluor and analyzed using
the Metamorph software (Universal Imaging, USA) and Origin
(OriginLab, USA). The global measurements of the whole-cell
pHF intensity during the experiment were obtained by designing a
region of interest around the perimeter of the cell surface
detectable in the TIRF field. Temporal variations of pHF were
expressed as background-subtracted DF/F0. F0 represents the
average basal fluorescence level obtained before stimulation and
Synaptic-Like Microvesicle Exocytosis of b-Cells
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DF corresponds to the change in fluorescence occurring during
stimulation. The fusion events of SLMVs were manually selected
and counted in areas of 6000 pixels (95 mm2) on cell surface.
A fluorescent spot was counted as ‘‘fusion event’’ when the pHF
signal of a single SLMV increased over basal by $4-fold.
Quantitative analysis of the subcellular distribution of synapto-
physin-pHluorin was carried out using the co-localization module
in the Imaris 7.6 software (Bit plane).
Statistical Analysis
The experiments were analyzed using the SAS statistical
package (SAS Inc., Cary NC, USA). Statistical differences were
tested by ANOVA. The data on frequency of fusion events at
different times were first analyzed by ANOVA, and multiple
comparisons of the means were then carried out using the post hoc
Dunnett test, with a discriminating p value of 0.05.
Results
Pancreatic b-cells possess two types of secretory vesicles, insulin-
containing large dense-core granules (LDCVs) and synaptic-like
microvesicles (SLMVs) [8]. These two categories of secretory
vesicles can be readily distinguished by immunocytochemistry and
confocal analysis in the pancreatic b-cell line MIN6 using
antibodies directed against endogenous insulin and synaptophysin,
two specific markers of LDCVs and SLMVs, respectively (Fig. 1A).
Individual LDCVs and SLMVs can also be visualized in living
cells by transfecting fluorescently labeled constructs that are
specifically targeted to each of these secretory organelles. Fig. 1B
shows TIRF images where LDCVs and SLMVs are labeled with
synaptophysin and phogrin constructs coupled to the fluorescent
protein mCherry, respectively. Both LDCVs and SLMVs
expressing the chimeric proteins appear as fluorescent spots of
different sizes representing secretory vesicles located in the
evanescent wave (TIRF illumination) and thus lying close to the
plasma membrane. The average diameter of SLMVs obtained by
plotting the fluorescence intensity of mCherry against the distance
from the center of the spot is close to that of fluorescent beads of
40 nm and LDCVs display sizes similar to beads of 400 nm
(Fig. 1C; [19,21]). These dimensions are in good agreement with
estimates obtained by electron microscopy [7].
While the process underlying the fusion of LDCVs in b-cells has
been intensively investigated, the kinetics of SLMV exocytosis and
the molecular mechanisms controlling it remain poorly under-
stood. We developed an imaging approach to specifically follow
SLMV exocytosis in real time. MIN6 cells were transiently
transfected with a chimeric construct consisting of rat synapto-
physin fused to a pH sensitive GFP mutant (syp-pHluorin) [13]. In
MIN6 cells exogenously expressed syp-pHluorin protein is
specifically targeted to SLMVs and not to LDCVs containing
insulin (Fig. 1D–E). Indeed, analysis of confocal images using a co-
localization software revealed that 96.962.4% (n= 5 cells) of the
GFP-labelled structures co-localize with endogenous synaptophy-
sin while only 8.866.8% (n= 5 cells) of them co-localize with
endogenous insulin. Since in the syp-pHluorin construct the
fluorescent moiety is located in the luminal domain of synapto-
physin and the internal pH of SLMVs is acidic (pH about 5.5), the
fluorescence signal emitted before the fusion event is low.
However, vesicle fusion with the plasma membrane and exposure
of pHluorin to the neutral pH of the extracellular medium (pH
about 7.4), results in a sharp rise in fluorescence intensity. This can
be readily detected by placing the region of interest (ROI) on the
whole-cell perimeter. Exposure of MIN6 cells to a combination of
secretagogues including 20 mM glucose, 100 nM IBMX, 1 mM
Forskolin and 30 mM KCl led to a transient increase in
fluorescence that peaks after about 30–50 sec of incubation
(Fig. 2A). Similar observations were made when the cells were
incubated in the presence of depolarizing concentrations of KCl
alone (Fig. 2B). The recording was stopped after about 300 sec to
avoid photo-bleaching. At this time point, the curves did not
always return to the basal level, probably because of complete
mixing of the SLMVs expressing syp-pHluorin with the plasma
membrane and incomplete recapture of the vesicle components
[22,23]. As is the case for the process of insulin secretion, SLMV
exocytosis was found to necessitate an increase in intracellular
Ca2+ concentration. Indeed, the rise in syp-pHluorin fluorescence
induced by the secretagogues was prevented by the L-type Ca2+
-channel blocker nifedipine. Moreover, SLMV fusion was
inhibited by hormones and neurotransmitters binding to Gi-
coupled membrane receptors such as epinephrine and somato-
statin [24] (Fig. 3).
Insulin exocytosis relies on the formation of complexes including
the SNARE proteins VAMP-2 and VAMP-3 (also called
cellubrevin) [25]. These proteins have previously been shown to
be associated to both LDCVs and SLMVs [25,26]. To assess
whether these SNARE proteins participate in SLMV exocytosis
MIN6 cells were transiently co-transfected with the syp-pHluorin
construct and with the catalytic subunit of tetanus toxin (TeTx).
The light chain of this neurotoxin is a Zn2+-dependent protease
that specifically cleaves VAMP-2 and -3 [27] and blocks insulin
exocytosis [25,28]. When expressed in MIN6 cells the TeTx light
chain was found to be uniformly distributed in the cytosol and to
efficiently cleave VAMP-2 (Figure S1 and S2 in File S1). As shown
in Fig. 4A, the cells expressing the catalytic subunit of TeTx
display an almost complete blockade of the response to the
secretagogues, indicating that VAMP-2 and/or VAMP-3 play a
central role in SLMV exocytosis. The vesicular SNAREs VAMP-2
and -3 form complexes with their partners located at the plasma
membrane. Botulinum neurotoxin serotype C (BoNT-C) has been
shown to selectively cleave the plasma membrane SNARE
Syntaxin-1 and to inhibit insulin secretion [29,30]. When
expressed in MIN6 cells the catalytic subunit of BoNT-C was
homogenously distributed in the cytosol (Figure S1 in File S1) and
resulted in Syntaxin 1 cleavage (Figure S2 in File S1). This was
accompanied with a substantial reduction in SLMV exocytosis
(Fig. 4B), pointing to an important contribution of Syntaxin-1 in
the fusion of these vesicles with the plasma membrane.
The fluorescence signal detected at the plasma membrane by
TIRF microscopy at each time point reflects the combination of
different processes including the fusion of SLMVs with the plasma
membrane (exocytosis), the internalization of vesicles retrieving the
syp-pHluorin construct from the cell surface (endocytosis) and the
re-acidification of the vesicle content. The relative contribution of
each of these processes can be evaluated by sequentially
monitoring the cells by epifluorescence (EPI) and TIRF micros-
copy. The use of EPI and TIRF microscopy in real time has the
advantage of providing a comparative analysis of fluorescence
changes in the whole cell and in its sub-membrane compartment,
respectively. Moreover, by using two illumination protocols one
can obtain information about the kinetics of exocytosis, endocy-
tosis and re-acidification during the application of the secreta-
gogues. Bath application of secretagogues induces in both EPI and
TIRF illuminations a rapid and transient increase of syp-pHluorin
fluorescence (Fig. 5). In particular, the syp-pHluorin fluorescence
under EPI indicates the prevalence of exocytosis (increase of syp-
pHluorin fluorescence) over the decay of syp-pHluorin fluores-
cence after fusion and re-acidification; under TIRF illumination,
the rising phase indicates prevalence of exocytosis over the two
Synaptic-Like Microvesicle Exocytosis of b-Cells
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processes that characterize the endocytic pathway: the fluores-
cence decay after fusion and re-acidification and the fluorescence
decay due to movement of vesicles out of the TIRF illumination
[19]. To evaluate the contribution of vesicle re-acidification, we
took advantage of the fact that this process relies on the activity of
a v-type ATPase [31]. Application of the stimulus in the presence
of the v-ATPase inhibitor Bafilomycin A1 [32], produces a change
in syp-pHluorin fluorescence that cannot recover because the
vesicles retain an alkaline interior (Fig. 5B). Thus, under these
conditions the EPI signal reflects only the amount of exocytosis
Figure 1. Two types of secretory vesicles in the pancreatic b-cell line MIN6B1. A. Confocal images showing double labeling of endogenous
synaptophysin (marker of SLMVs) and insulin (marker of LDCVs) in the pancreatic b-cell line MIN6B1. Lower panels present details of the same images
at higher magnification. Note that in the merge images there is no colocalization between the two signals. B. TIRF images of a 40 nm red fluorescent
bead, a representative SLMV expressing synaptophysin-mCherry, a 400 nm red fluorescent bead and a representative LDCV. C. Average radial sweeps
of 20 TIRF images. Red lines are the means of the measured values. The 40-nm beads are significantly smaller than LDCVs but display apparent sizes
similar to SLMVs. In contrast, LDCVs exhibit apparent sizes similar to 400-nm beads. Error bars indicate SD. Bar, 0.5 mm. Intracellular distribution of
synaptophysin-pHluorin. D. MIN6 cells were transfected with synaptophysin-pHluorin and immunolabeling performed with antibodies against GFP,
endogenous insulin or synaptophysin. Images were acquired with confocal microscope and quantitative analysis carried out using the co-localization
module in the Imaris 7.6 software (Bit plane). On the top: the left panel shows the localization of synaptophysin-pHluorin revealed using the GFP
antibody (green). The middle panel shows immunolabeling against endogenous insulin (red) and the right panel the merged images. The panels on
the bottom present higher magnifications of the top pictures. The analysis of the images shows 8.866.8% (n= 5 cells) co-localization between the
green and the red signals. E. same experiment as D. but with immunolabeling against synaptophysin (red). The analysis of the images indicates
96.962.4% (n= 5 cells) co-localization of the two signals. Bars: 12 mm.
doi:10.1371/journal.pone.0087758.g001
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Figure 2. Stimulation of exocytosis and endocytosis of SLMVs in MIN6B1 cells with different secretagogues: whole-cell studies. A.
Time-course of cocktail-induced (glucose 20 mM; KCl 30 mM; forskolin 10 mM, IBMX 100 mM) pHluorin fluorescence intensity changes analyzed by
TIRF illumination. The curve represents the whole-cell pHluorin fluorescence signal, expressed as DF/F0 obtained averaging results from 13 cells. B.
Same as A. but induced by KCl 30 mM. The curve is obtained by averaging results from 9 cells. Data points are collected every 200 ms and represent
mean values 6 SD.
doi:10.1371/journal.pone.0087758.g002
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and is independent of the re-acidification. To quantitatively
estimate the kinetics of re-acidification we subtracted the curve
recorded in the absence of the v-ATPase inhibitor (reflecting a
balance between exocytosis and re-acidification) and the EPI curve
obtained in the presence of Bafilomycin A1 (representing
exocytosis only) (Fig. 5D). The resulting curve permits to directly
estimate the kinetic of re-acidification. By analyzing this curve, we
found that SLMVs re-acidification occurs in two distinct phases;
Figure 3. Effect of Somatostatin and Epinephrine on exocytosis of SLMVs. A. Time-course of cocktail-induced (glucose 20 mM; KCl 30 mM;
forskolin 10 mM, IBMX 100 mM) pHluorin fluorescence intensity in the absence or in the presence of somatostatin (500 nM) obtained with TIRF
illumination. The curve represents the whole-cell pHluorin fluorescence signal, expressed as DF/F0 obtained averaging results from 5 and 11 cells,
respectively. B. same experiment as A. but in the absence or in the presence of epinephrine (1 mM). The curve represents the whole-cell pHluorin
fluorescence signal, expressed as DF/F0 obtained averaging results from 4 and 7 cells, respectively. C–D. Histograms represent the amplitudes (DF/F0)
of the cocktail-induced pHluorin fluorescence intensity change in the absence or in the presence of somatostatin or epinephrine.
doi:10.1371/journal.pone.0087758.g003
Synaptic-Like Microvesicle Exocytosis of b-Cells
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e87758
immediately after the stimulus the process displays an exponential
rise for about 20 sec followed by a rapid return to baseline levels.
The re-acidification increases again in a more constant and linear
manner about 100 sec after the beginning of the stimulus. We then
analyzed the TIRF curves. We noticed that Bafilomycin A1 has
little or no effect on the rising and decay phases of the syp-
pHluorin fluorescence signal. As the contribution of the re-
acidification process is eliminated by the presence of the v-ATPase
inhibitor, the decrease of the syp-pHluorin signal detected by
TIRF illumination reflects exclusively the movement of the
SLMVs. We found that the endocytosed vesicles move out of
the TIRF illumination before the occurrence of the re-acidification
process. The kinetic of this movement can be quantitatively
assessed by subtracting the normalized TIRF curve (representing
Figure 4. Inhibition of SLMV exocytosis by clostridial neurotoxins. A. Time-course of cocktail-induced (glucose 20 mM; KCl 30 mM; forskolin
10 mM, IBMX 100 mM) pHluorin fluorescence intensity obtained with TIRF illumination in cell transfected with a control plasmid or with tetanus
neurotoxin-tomato (TeTX). The curve represents the whole-cell pHluorin fluorescence signal, expressed as DF/F0 obtained averaging results from 3
and 9 cells, respectively. B. The same as A. but in cells transfected with a control plasmid or with GFP-botulinum neurotoxin C (BoNT/C). Since the
GFP-tagged BoNT/C light chain is uniformly distributed in the cytoplasm, the fluorescence signal originating from this construct in the TIRFM
evanescent field was negligible. The curve represents the whole-cell pHluorin fluorescence signal, expressed as DF/F0 obtained averaging results from
5 and 6 cells, respectively. C–D. Histograms represent the amplitudes DF/F0) of the cocktail-induced pHluorin fluorescence intensity change in cells
transfected with control plasmids or with TeTX or BoNT/C.
doi:10.1371/journal.pone.0087758.g004
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exocytosis and movement) from the normalized EPI curve
obtained in the presence of Bafilomycin A1 (representing
exocytosis only) (Fig. 5C; see also Text S1 in File S1). Similar to
the re-acidification, the endocytosis curve shows a bimodal
distribution with a transient peak immediately after the stimulus
followed by a steady and slow increase.
The analysis of cells expressing syp-pHluorin by TIRF
microscopy permits to visualize not only the global fluorescence
changes occurring at or very close to the plasma membrane but
also to study the exo-endocytosis processes of individual vesicles.
Single fusion events are recognized by the appearance of the syp-
pHluorin signal in the evanescent field illumination (Fig. 1). By
Figure 5. Characteristics of stimulation-evoked exo-endocytosis and reacidification of SLMVs in MIN6B1 cells: whole-cell studies. A.
Time-course of cocktail-induced (glucose 20 mM; KCl 30 mM; forskolin 10 mM, IBMX 100 mM) pHluorin fluorescence intensity obtained with TIRF and
EPI illumination. The curve represents the whole-cell pHluorin fluorescence signal, expressed as DF/F0 obtained averaging results from 5 cells. B. Same
as A. but in the presence of BafA1 (2.5 mM; n= 4 cells). The rate of spontaneous alkalinization (TIRF 0.0860.006 DF/F0; EPI 0.09660.01 DF/F0) was
calculated in the pre-stimulus period and subtracted from the curves. Not that the curve under EPI represents a cumulative curve of exocytosis. C.
Cumulative curve of estimated endocytosis (movement out of the TIRF field) obtained by subtracting the normalized curves of the pHluorin
fluorescence signal measured under TIRF and under EPI both in the presence of BafA1 (curves in B). Curves in B were normalized to the maximum
fluorescence obtained under EPI and TIRF, respectively in the presence of BafA1 for each cell. D. Cumulative curve of estimated reacidification
obtained by subtracting the normalized curves of the pHluorin fluorescence signal obtained under EPI in the absence of BafA1 (curve in A) from the
curve in the presence of the drug (curve in B). Curves in A and B were normalized to the maximum fluorescence obtained under EPI in the presence
of BafA1 for each cell.
doi:10.1371/journal.pone.0087758.g005
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placing the ROI on top of each recognized fusion event we
calculated the number of exocytotic events/s (rate of exocytosis) in
syp-pHluorin-transfected cells before and after the stimulus. As
expected, the number of exocytotic events in cells incubated with a
combination of secretagogues or with 30 mM KCl displays a
significant increase in the rate of exocytosis during the first 25 sec
Figure 6. Stimulation triggers SLMV exocytosis in MIN6B1 cells: single vesicle studies. A-B Temporal distribution of the fusion events on a
6000 pixel area (95 mm2)/300 ms before and after the bath application of the cocktail (glucose 20 mM; KCl 30 mM; forskolin 10 mM, IBMX 100 mM) or
of KCl (30 mM). Note the significant increase in the frequency of pHluorin-mediated fusion events after bath application of both cocktail and KCl
(n = 4 cells, from 0 to 75 sec, p,0.05 multiple comparisons, Dunnett test).
doi:10.1371/journal.pone.0087758.g006
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after stimulation (Fig. 6). It then progressively decreases but
remains higher than the number of events preceding the
stimulation for at least 5 min. Glucose is the main physiological
stimulus of insulin exocytosis [33]. Interestingly, the kinetic of
exocytosis was significantly different when cells were incubated
with 20 mM glucose (Fig. 7). Similar to insulin secretion the rate of
SLMVs exocytosis starts to increase 3 min after the stimulus and
remains elevated for at least 30 min. This is consistent with the
signaling pathway underlying stimulus-secretion coupling elicited
by glucose. Indeed, glucose is first metabolized by the cells to
generate ATP. This, in turn, causes closure of ATP-sensitive K+
channels, membrane depolarization and Ca2+ entry through
voltage-gated Ca2+ channels [33].
Beside the quantitative assessment of the number of fusion
events, monitoring of the cells by TIRF microscopy permits a
detailed analysis of the dynamics of the fusion process. This led us
to distinguish two categories of fusion events: transient events
characterized by a rise in fluorescence that disappears within
about 2 sec (Type 1) and long lasting events in which the
fluorescence signal persists at the membrane for several seconds
and fades only after about 10 sec (Type 2) (Fig. 8A). Under resting
conditions close to 70% of the fusion events were of Type 1 while
30% were classified of Type 2 (Fig. 8B). This ratio was significantly
modified after stimulation of the cells. Indeed, 50% or more of the
fusion events observed upon incubation of the cells in the presence
of secretagogues were of Type 2 (Fig. 8B).
Discussion
Pancreatic b-cells play a pivotal role in the control of body
metabolism. A detailed knowledge of the physiology of these cells
is essential to understand the causes of defective insulin release in
pre-diabetic and diabetic conditions and to favor the development
of new therapeutic approaches for the treatment of this disease.
Insulin is stored in LDCVs and is released in response to a variety
of nutrients, hormones and neurotransmitters [33]. However, b-
cells release many other signaling molecules that are believed to
modulate their functional status and to affect their secretory
activity as well as their survival and proliferation rate. Among
them, GABA has attracted considerable attention after the
demonstration that in rodents this neurotransmitter inhibits
Figure 7. SLMV exocytosis triggered by 20 mM glucose: single vesicle studies. Temporal distribution of the fusion events before and after
the bath application of glucose (20 mM). Note the significant increase in the frequency of pHluorin-mediated fusion events after bath application of
glucose (n = 5 cells, from 600 sec to 1800 sec, p,0.05 multiple comparisons, Dunnett test).
doi:10.1371/journal.pone.0087758.g007
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glucagon secretion from pancreatic b-cells and displays autocrine
effects on the secretory properties and proliferation of b-cells
[4,10,11]. Recent studies confirmed a role for GABA in the
control of pancreatic endocrine functions in human islets [34] and
revealed that the GABA signaling system is compromised in islets
obtained from Type 2 diabetic individuals [35]. Many non-peptide
signaling molecules released by b-cells, including a fraction of
GABA, are stored in SLMVs [8]. In contrast to LDCV exocytosis,
which has been intensively investigated, the mechanisms govern-
ing exo-endocytosis processes of SLMVs are still largely unknown.
This lack of information is mainly due to difficulties in studying
these organelles with standard techniques. Indeed, their small size
renders conventional capacitance measurements technically de-
manding and the repertoire of molecules residing inside the
SLMVs is still not fully established. Recent studies performed with
cell-attached membrane capacitance suggested that SLMVs
undergo regulated exocytosis as neuronal synaptic vesicles. Similar
to insulin secretion, SLMVs were reported to fuse with the plasma
membrane in response to glucose and to an increase in cytosolic
calcium [36]. Although these studies provided an initial charac-
terization of the properties of SLMVs in b-cells, a number of key
questions regarding the kinetics of the exocytotic and recycling
processes and the molecular determinants governing them
remained unsettled.
In this study, we developed a strategy to specifically monitor
SLMV exocytosis from insulin-secreting cells. In recent years,
membrane tracer approaches combined with sensitive fluorescent
imaging techniques have emerged as superior tools to study the
Figure 8. Two modes of exo-endocytosis: single vesicle studies. A. Serial TIRF images illustrate typical type 1 and type 2 fusion events of
SLMVs expressing syn-pHluorin. Time 0 represents the fusion event. Each frame corresponds to 150 milliseconds. The syn-pHluorin labelled vesicle
start to fuse with the plasma membrane at 0. B. Histograms representing the ratio between type 1 and type 2 fusion events under basal conditions or
in the presence of different stimuli (cocktail, KCl and glucose) (n = 5 cells, t-test, p,0.05).
doi:10.1371/journal.pone.0087758.g008
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fate of specific organelles and to monitor secretion processes in real
time. In particular, the use of chimeric constructs including a pH
sensitive form of GFP (termed super-ecliptic pHluorin) is
recognized as the state-of-the-art approach for imaging secretion
processes in living cells [37]. Indeed, the attachment of pHluorin
to the interior of various vesicle proteins such as synaptobrevin
[32], synaptophysin [13] or VGLUT1 [19,38] allowed the analysis
in real-time of exocytosis and recycling of specific populations of
secretory organelles. Here we took advantage of this life imaging
approach to assess the effect of several secretagogues and to dissect
the mechanisms underlying SLMV fusion in pancreatic b-cells.
Our data indicate that in b-cells SLMV exocytosis occurs in a
regulated fashion and is triggered by the same stimuli that elicit
insulin exocytosis. As is the case for LDCVs, fusion of SLMVs with
the plasma membrane involves opening of voltage-gated L-type
Ca2+ channels and a consequent increase in intracellular Ca2+
concentration. We also provide data indicating that SLMV
exocytosis is negatively controlled by agonists that bind to Gi-
coupled receptors and potently inhibit insulin secretion such as
epinephrine and somatostatin [24]. These data confirm and
further extend the results obtained using capacitance measure-
ments in INS-1 and primary rat b-cells [36].
In our study, we also investigated the molecular mechanisms
underlying the fusion of SLMVs with the plasma membrane.
Using clostridial toxins we were able to show that SLMV
exocytosis in b-cells relies on the activity of VAMP-2/23 and
Syntaxin-1, a group of SNARE proteins playing a central role in
neuronal transmitter release and in insulin secretion [39,40]. The
level of these proteins has been shown to be reduced under
physiopathological conditions and in diabetes animal models
[41,42]. Moreover, VAMP-2 and Syntaxin-1 are strongly dimin-
ished in pancreatic islets isolated from Type 2 diabetic patients
[43]. Thus, under physiopathological conditions in which glucose
metabolism and Ca2+ signaling are defective and/or the expres-
sion of VAMP-2 and Syntaxin-1 is reduced the release of
compounds located in SLMVs is likely to be altered. This may
potentially contribute to defective b-cell function in pre-diabetic
and diabetic conditions.
The imaging technique used in this study permitted to
characterize the dynamics of the exocytotic and recycling
processes of b-cell SLMVs with unprecedented details. Although
our approach focuses on a specific cell area that is in contact with
the coverglass, our observations are likely to be representative of
the behaviour of SLMVs in the rest of the cell. Indeed, although
with the limitation of the imaging techniques studying secretion in
the cellular area in contact with the coverglass, we were able to
show that endocytosis and re-acidification of the vesicles are
initiated immediately after the fusion of SLMVs with the plasma
membrane and display bimodal kinetics. As is the case in neuronal
cells, SLMVs are recycled rapidly and are likely to be again
available for subsequent fusion events in a relatively short time.
Compared to endogenous vesicular proteins that remain clustered
at the site of fusion, pHluorin constructs tend to diffuse more in the
plasma membrane [22,23]. Thus, it is possible that the recapture
of the SLMV components is even more efficient than detected by
our experimental approach. In view of the fact that b-cells contain
around 39500 SLMVs and only a very small fraction of them is
undergoing exocytosis even under maximal stimulation, a shortage
of these secretory organelles is very unlikely under physiological
conditions. Interestingly, both endocytosis and recycling of
SLMVs display a bimodal pattern. The two distinct phases of
endocytosis and recycling observed may possibly reflect the
existence of different vesicle pools: one readily available for fusion
and rapidly recycled and another mobilized only upon prolonged
exposure to secretagogues. This issue will need to be investigated
in more details in future studies.
Careful analysis of individual fusion episodes revealed the
existence of at least two types of exocytotic events: short short-lived
events that predominate under basal conditions and long-lasting
events more frequent under stimulatory conditions. At present, the
functional significance of these two modes of exocytosis remains to
be elucidated and several explanations can be envisaged. One
possibility is that short living fusions correspond to events in which
the vesicle and the plasma membrane components are not fully
merging. Under these conditions, closure of the fusion pore could
permit immediate re-acidification of the vesicle content and rapid
recycling. In contrast, long-lasting fusions may represent exocy-
totic events in which the vesicle and the plasma membrane are
fully mixing. In this case, recapture of the vesicle components and
re-acidification may require a longer period. Another possible
explanation for our findings is that when secretion is slow (basal
conditions) most of the vesicles can be rapidly endocytosed and
recycled while under strong stimulatory conditions the capacity of
the cells to retrieve the vesicle components from the plasma
membrane becomes rate-limiting. Under these circumstances the
vesicle components would accumulate at the cell surface leading to
a persistently elevated syp-pHluorin fluorescence signal.
In conclusion, the imaging approach described in this study
allowed careful analysis of the molecular determinants and of the
kinetics of exocytosis and recycling of b-cell SLMVs. We obtained
new information about the signaling cascades and the molecular
components involved in SLMV exocytosis and were able to
monitor the characteristics of single fusion events. In the future,
the use of our methodology will help clarifying the precise
physiological role of these organelles and will permit to determine
whether inappropriate release of molecules stored in SLMVs
contributes to b-cell dysfunction occurring in pre-diabetic and
diabetic state.
Supporting Information
File S1 Figure S1) The transfected catalytic subunits of
clostridial toxins are uniformly distributed in the cytosol of
MIN6 cells. Figure S2) Expression of the light chains of TeTx and
BoNT-C in MIN6 cells results in efficient cleavage of VAMP2 and
Syntaxin 1. Text S1) Detailed explanation of the procedure used
for the analysis of the different parameters of SLMVs recycling.
(PDF)
Acknowledgments
We thank Drs L. Lagnado (MRC Laboratory of Molecular Biology,
Cambridge, U.K.), N. Ben Fredj (MRC Centre for Developmental
Neurobiology, King’s College London, U.K.), J. Lang (University of
Bordeaux, CBMN, UMR 5248, France) and Y. Goda (MRC Laboratory
of Molecular Cell Biology, Cell Biology Unit, University College London,
U.K.) for generously providing the indicated plasmids.
Author Contributions
Conceived and designed the experiments: AB LP PB RR. Performed the
experiments: AB LP PB. Analyzed the data: AB LP PB RR. Wrote the
paper: PB RR.
Synaptic-Like Microvesicle Exocytosis of b-Cells
PLOS ONE | www.plosone.org 12 February 2014 | Volume 9 | Issue 2 | e87758
References
1. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest
116: 1802–1812.
2. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, et al. (2007)
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-
mitochondrial ROS production and activity. J Physiol 583: 9–24.
3. Steiner DJ, Kim A, Miller K, Hara M (2010) Pancreatic islet plasticity:
Interspecies comparison of islet architecture and composition. Islets 2: 135–145.
4. Franklin IK, Wollheim CB (2004) GABA in the endocrine pancreas: its putative
role as an islet cell paracrine-signalling molecule. J Gen Physiol 123: 185–190.
5. Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine
pancreas: 35 years of research but the enigma remains. Endocr Rev 28: 84–116.
6. Braun M, Wendt A, Karanauskaite J, Galvanovskis J, Clark A, et al. (2007)
Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP
from LDCV in rat pancreatic beta cells. J Gen Physiol 129: 221–231.
7. Braun M, Wendt A, Birnir B, Broman J, Eliasson L, et al. (2004) Regulated
exocytosis of GABA-containing synaptic-like microvesicles in pancreatic beta-
cells. J Gen Physiol 123: 191–204.
8. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, et al. (1991) GABA and
pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and
GABA with synaptic-like microvesicles suggests their role in GABA storage and
secretion. Embo J 10: 1275–1284.
9. Gammelsaeter R, Froyland M, Aragon C, Danbolt NC, Fortin D, et al. (2004)
Glycine, GABA and their transporters in pancreatic islets of Langerhans:
evidence for a paracrine transmitter interplay. J Cell Sci 117: 3749–3758.
10. Ligon B, Yang J, Morin SB, Ruberti MF, Steer ML (2007) Regulation of
pancreatic islet cell survival and replication by gamma-aminobutyric acid.
Diabetologia 50: 764–773.
11. Dong H, Kumar M, Zhang Y, Gyulkhandanyan A, Xiang YY, et al. (2006)
Gamma-aminobutyric acid up- and downregulates insulin secretion from beta
cells in concert with changes in glucose concentration. Diabetologia 49: 697–
705.
12. Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, et al. (2008)
Novel aspects of the molecular mechanisms controlling insulin secretion.
J Physiol 586: 3313–3324.
13. Granseth B, Odermatt B, Royle SJ, Lagnado L (2006) Clathrin-mediated
endocytosis is the dominant mechanism of vesicle retrieval at hippocampal
synapses. Neuron 51: 773–786.
14. Ben Fredj N, Hammond S, Otsuna H, Chien CB, Burrone J, et al. (2010)
Synaptic activity and activity-dependent competition regulates axon arbor
maturation, growth arrest, and territory in the retinotectal projection. J Neurosci
30: 10939–10951.
15. Lilla V, Webb G, Rickenbach K, Maturana A, Steiner DF, et al. (2003)
Differential gene expression in well-regulated and dysregulated pancreatic beta-
cell (MIN6) sublines. Endocrinology 144: 1368–1379.
16. Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of
components of the machinery of exocytosis of insulin-secreting cells by
microRNAs. Biol Chem 389: 305–312.
17. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhauser C, et al. (2004)
Astrocytes contain a vesicular compartment that is competent for regulated
exocytosis of glutamate. Nat Neurosci 7: 613–620.
18. Cheviet S, Bezzi P, Ivarsson R, Renstrom E, Viertl D, et al. (2006) Tomosyn-1 is
involved in a post-docking event required for pancreatic beta-cell exocytosis.
J Cell Sci 119: 2912–2920.
19. Marchaland J, Cali C, Voglmaier SM, Li H, Regazzi R, et al. (2008) Fast
subplasma membrane Ca2+ transients control exo-endocytosis of synaptic-like
microvesicles in astrocytes. J Neurosci 28: 9122–9132.
20. Toomre D (2012) Alignment and calibration of total internal reflection
fluorescence microscopy systems. Cold Spring Harb Protoc 2012: 504–509.
21. Cali C, Marchaland J, Regazzi R, Bezzi P (2008) SDF 1-alpha (CXCL12)
triggers glutamate exocytosis from astrocytes on a millisecond time scale:
Imaging analysis at the single-vesicle level with TIRF microscopy.
J Neuroimmunol.
22. Opazo F, Punge A, Buckers J, Hoopmann P, Kastrup L, et al. (2010) Limited
intermixing of synaptic vesicle components upon vesicle recycling. Traffic 11:
800–812.
23. Willig KI, Rizzoli SO, Westphal V, Jahn R, Hell SW (2006) STED microscopy
reveals that synaptotagmin remains clustered after synaptic vesicle exocytosis.
Nature 440: 935–939.
24. Sharp GW (1996) Mechanisms of inhibition of insulin release. Am J Physiol 271:
C1781–1799.
25. Regazzi R, Wollheim CB, Lang J, Theler JM, Rossetto O, et al. (1995) VAMP-2
and cellubrevin are expressed in pancreatic beta-cells and are essential for
Ca(2+)-but not for GTP gamma S-induced insulin secretion. Embo J 14: 2723–
2730.
26. Mizuta M, Kurose T, Miki T, Shoji-Kasai Y, Takahashi M, et al. (1997)
Localization and functional role of synaptotagmin III in insulin secretory vesicles
in pancreatic beta-cells. Diabetes 46: 2002–2006.
27. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, et al.
(1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by
proteolytic cleavage of synaptobrevin. Nature 359: 832–835.
28. Regazzi R, Sadoul K, Meda P, Kelly RB, Halban PA, et al. (1996) Mutational
analysis of VAMP domains implicated in Ca2+-induced insulin exocytosis.
Embo J 15: 6951–6959.
29. Lang J, Zhang H, Vaidyanathan VV, Sadoul K, Niemann H, et al. (1997)
Transient expression of botulinum neurotoxin C1 light chain differentially
inhibits calcium and glucose induced insulin secretion in clonal beta-cells. FEBS
Lett 419: 13–17.
30. Ohara-Imaizumi M, Nishiwaki C, Kikuta T, Kumakura K, Nakamichi Y, et al.
(2004) Site of docking and fusion of insulin secretory granules in live MIN6 beta
cells analyzed by TAT-conjugated anti-syntaxin 1 antibody and total internal
reflection fluorescence microscopy. J Biol Chem 279: 8403–8408.
31. Sankaranarayanan S, Ryan TA (2000) Real-time measurements of vesicle-
SNARE recycling in synapses of the central nervous system. Nat Cell Biol 2:
197–204.
32. Sankaranarayanan S, Ryan TA (2001) Calcium accelerates endocytosis of
vSNAREs at hippocampal synapses. Nat Neurosci 4: 129–136.
33. Rorsman P, Braun M (2012) Regulation of Insulin Secretion in Human
Pancreatic Islets. Annu Rev Physiol.
34. Braun M, Ramracheya R, Bengtsson M, Clark A, Walker JN, et al. (2010)
Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in
human pancreatic beta-cells. Diabetes 59: 1694–1701.
35. Taneera J, Jin Z, Jin Y, Muhammed SJ, Zhang E, et al. (2012) gamma-
Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in
type 2 diabetes. Diabetologia 55: 1985–1994.
36. MacDonald PE, Obermuller S, Vikman J, Galvanovskis J, Rorsman P, et al.
(2005) Regulated exocytosis and kiss-and-run of synaptic-like microvesicles in
INS-1 and primary rat beta-cells. Diabetes 54: 736–743.
37. Miesenbock G (2012) Synapto-pHluorins: genetically encoded reporters of
synaptic transmission. Cold Spring Harb Protoc 2012: 213–217.
38. Voglmaier SM, Kam K, Yang H, Fortin DL, Hua Z, et al. (2006) Distinct
endocytic pathways control the rate and extent of synaptic vesicle protein
recycling. Neuron 51: 71–84.
39. Lang J (1999) Molecular mechanisms and regulation of insulin exocytosis as a
paradigm of endocrine secretion. Eur J Biochem 259: 3–17.
40. Rorsman P, Renstrom E (2003) Insulin granule dynamics in pancreatic beta
cells. Diabetologia 46: 1029–1045.
41. Torrejon-Escribano B, Escoriza J, Montanya E, Blasi J (2011) Glucose-
dependent changes in SNARE protein levels in pancreatic beta-cells.
Endocrinology 152: 1290–1299.
42. Dubois M, Vacher P, Roger B, Huyghe D, Vandewalle B, et al. (2007)
Glucotoxicity inhibits late steps of insulin exocytosis. Endocrinology 148: 1605–
1614.
43. Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T (2006) Impaired gene and
protein expression of exocytotic soluble N-ethylmaleimide attachment protein
receptor complex proteins in pancreatic islets of type 2 diabetic patients.
Diabetes 55: 435–440.
Synaptic-Like Microvesicle Exocytosis of b-Cells
PLOS ONE | www.plosone.org 13 February 2014 | Volume 9 | Issue 2 | e87758
